| Views | |
|---|---|
| Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 | 54 |
| January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | |
|---|---|---|---|---|---|---|---|
| Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 | 0 | 0 | 0 | 3 | 9 | 6 | 1 |
| Views | |
|---|---|
| dic.2022-1-125955.pdf | 9 |
| Views | |
|---|---|
| Canada | 24 |
| Russia | 7 |
| United States | 5 |
| Vietnam | 5 |
| United Kingdom | 2 |
| A2 | 1 |
| China | 1 |
| Ecuador | 1 |
| Japan | 1 |
| Kuwait | 1 |
| Views | |
|---|---|
| Ottawa | 23 |
| Hanoi | 5 |
| Ambato | 1 |
| Hartlepool | 1 |
| Houston | 1 |
| Kuwait | 1 |
| Mountain View | 1 |
| Parañaque | 1 |
| Tokyo | 1 |
| Toronto | 1 |